# FDA recall D-0094-2026

> **GenoGenix  LLC** · Class I · drug recall initiated 2025-07-30.

## Product

NAD+ (Nicotinamide adenine dinucleotide) for Injection, a) 100 mg/mL b) 200 mg/mL, 10 mL multi-dose amber vials, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.

## Reason for recall

Microbial Contamination of Sterile Products: elevated endotoxin levels

## Distribution

US Nationwide.

## Key facts

- **Recall number:** D-0094-2026
- **Recalling firm:** GenoGenix  LLC
- **Classification:** Class I
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2025-07-30
- **Report date:** 2025-10-15

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Boca Raton, FL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0094-2026

## Citation

> AI Analytics. FDA recall D-0094-2026. Retrieved 2026-07-20 from https://api.ai-analytics.org/recall/D-0094-2026. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*